Just over a year after acquiring the FSG business from Vivendi for
$360 million (€307m), Pall Corp has reported a healthy hike in
fiscal third-quarter sales and profits and once again raised its
earnings forecast for 2003.
The European Union's Employment, Social Policy, Health and Consumer
Affairs Council agreed on 2 June not to press ahead with proposals
to implement a mandatory centralised marketing authorisation scheme
for all medicines.
One of Pfizer Global R&D's major research facilities, based in
Nerviano, Italy, has signed an expanded agreement with PerkinElmer
in which the latter will provide repair, maintenance and validation
services for sophisticated...
The Automation Partnership, a UK-based specialist in life science
automation systems, has launched a new low volume cell dispenser
for SelecT, the firm's automated cell culture system. The dispenser
was unveiled at the annual...
Research into genomes of the natural world took a step forward this
week with the announcement from Diversa corporation that it is to
jointly collaborate with the US Department of Energy's Joint Genome
Institute (JGI) to discover...
Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Canadian drug discovery company Phytobiotech has entered into an
agreement to supply Achillion Pharmaceuticals with purified, plant
derived small molecules (phytochemicals) from its PurePhytoLib
library. The collaboration marks a...
An expert group on intellectual property rights (IPRs) has warned
that rules governing the protection of copyrights, database rights
and patents hamper scientific endeavour and must be changed 'in the
interest of society',...
Total revenues for the four emerging sectors of protein array,
crucial antibody array, peptide biochip, protein biochip, and
solution bead/particle array were estimated at $90 million
(€83million) in 2002, writes market analyst Business...